all report title image
  • Published In : Jan 2024
  • Code : CMI2603
  • Pages :180
  • Formats :
      Excel and PDF
  • Industry : Medical Devices

The Global Blood Gas Analyzers Market size is estimated to be valued at US$ 2.36 Bn in 2023 and is expected to reach US$ 3.46 Bn by 2030, growing at a Compound Annual Growth Rate (CAGR) of 5.6% from 2023 to 2030.

Blood Gas Analyzers Market Regional Insights

North America has dominated the global blood gas analyzers market gaining a market share of 44.3%. The region is home to some of the largest medical device companies as well as the presence of advanced healthcare infrastructure and facilities. Additionally, growing prevalence of chronic respiratory diseases, such as chronic obstructive pulmonary disease (COPD) and asthma, along with high healthcare spending have been driving the sales of blood gas analyzers in the region. Many leading global players including Abbott Laboratories, Siemens Healthcare, and Radiometer Medical have their home base in the U.S., which gives them an added advantage in serving the North America market. The awareness regarding critical care testing is also higher among physicians as well as patients in this region.

Europe is also a significant market for blood gas analyzers market owing to the rising demand for advanced analyzers capable of rapid multi-parameter testing from large, medium, and small hospitals across major European countries. Increasing healthcare infrastructure and accessibility have resulted in greater volumes of diagnostic tests being performed. This is driving the need for high-throughput blood gas analyzers to efficiently handle workloads. Most modern instruments can perform up to 120 tests per hour with high accuracy.

The Asia Pacific region, on the other hand, has emerged as the fastest growing market for blood gas analyzers globally. Countries like China, India, and Japan are witnessing rapid economic development along with growing investments in the healthcare sector. This has improved access to advanced diagnostic technologies. Also, the rising geriatric population and increasing healthcare expenditures are supporting the market growth. Many global players are focusing on establishing their manufacturing facilities in countries like China and India to serve locals as well as other emerging markets. This is significantly improving the affordability of products. Furthermore, growing incidence of lifestyle diseases and improving patient awareness for critical care diagnostics are boosting the sales of blood gas analyzers. The region is also witnessing increasing exports of cost-effective blood gas analyzers to other parts of the world. This is positively impacting the overall revenue.

Figure 1. Global Blood Gas Analyzers Market Share (%), By Region, 2023


To learn more about this report, request a free sample copy

Analyst’s Views

The global blood gas analyzers market has strong growth potential driven by the rising geriatric population and increasing prevalence of chronic respiratory diseases. The market is expected to see higher adoption of portable and benchtop blood gas analyzers as they offer convenience of point-of-care testing. North America will continue dominating the market supported by advanced healthcare infrastructure and wide access to care facilities. However, Asia Pacific is likely to emerge as the fastest growing market over the next 5 years.

Reimbursement challenges in various developing nations can negatively impact the market expansion. Nonetheless, increasing healthcare spending in Asia Pacific and Latin America will open new revenue opportunities for players. Manufacturers should focus on launching affordable products to capitalize on opportunities in price-sensitive markets. Furthermore, integrating connectivity features will help users access patient data remotely and enable prompt clinical decision making.

Blood Gas Analyzers Market Drivers:

  • Increasing prevalence of respiratory diseases: The global prevalence of respiratory diseases has been rising steadily over the past few decades. Chronic respiratory conditions, such as asthma and COPD, affect a huge patient population worldwide and impose a significant burden on healthcare systems. Lung function testing is crucial for the effective diagnosis and management of such diseases. Blood gas analyzers play a vital role in pulmonary function testing as they help clinicians monitor the level of oxygen and carbon dioxide in a patient's bloodstream, along with other critical blood gas parameters. The rising disease burden of respiratory illnesses has led to a parallel increase in demand for pulmonary diagnostic procedures including blood gas analysis. For instance, according to World Health Organization, in March 2023, chronic obstructive pulmonary disease (COPD) was the third leading cause of death worldwide, causing 3.2 million deaths in 2019. Nearly 90% of COPD deaths in those under 70 years of age occur in low- and middle-income countries (LMIC).
  • Advancements in blood gas analyzer technology: Technological advancements have allowed modern blood gas analyzers to achieve higher levels of reliability, efficiency, and user-friendliness compared to previous generations of devices. Analyzer models now offer faster turnaround times, require smaller blood or plasma sample volumes, and provide more accurate and precise test results. Platforms have become fully automated with advanced features such as quality control, data management, and connectivity capabilities. Newer blood gas analyzers use sophisticated measurement techniques like optical sensing which eliminate issues like sensor drift and produce consistent readings over the lifetime of the device. Bi-directional interfacing with laboratory information systems enables real-time data sharing. Portable blood gas analyzers have become more portable and user-friendly as well. These trends have significantly enhanced the value proposition of blood gas testing.
  • Adoption of point-of-care testing: The adoption of point-of-care testing is significantly driving the growth of the global blood gas analyzers market. Point-of-care testing offers convenience and faster results, allowing for quick clinical decision making. It enables testing to be performed near the patient in various hospital settings like emergency rooms, intensive care units, operating rooms and also in alternative site settings like ambulances, physician offices and homes. This growth in point-of-care testing is reflecting the need for timely diagnostic information to optimize patient care. By facilitating more rapid analysis of blood gas, electrolytes and metabolites directly from the patient's blood sample without requiring preparation or specialized training, point-of-care testing offers advantages over laboratory-based testing. Thus, continuous development and wider adoption of point-of-care technologies for blood gas and critical care parameter testing is expected to remain a major growth driver for the global blood gas analyzers market beyond COVID-19 as well. The demand for timely diagnostic information to optimize patient management will keep bolstering the point-of-care and near-patient testing market in the coming years.

Blood Gas Analyzers Market Opportunities:

  • Emerging markets in developing countries: Emerging markets in developing countries present a great opportunity for growth in the global blood gas analyzers market. With rising incomes and growing public awareness of healthcare, demand for advanced medical diagnostic technologies is increasing rapidly in these nations. Many developing economies have large and young populations. Non-communicable diseases such as cardiovascular disorders and diabetes are on the rise. Timely diagnosis and management of such conditions often depends on blood gas analysis. It provides critical insights into patient oxygenation and acid-base balance, aiding the treatment and monitoring of chronic illnesses. This makes blood gas analyzers a valuable addition to healthcare facilities. According to World Bank data, certain developing regions like South Asia and Sub-Saharan Africa are expected to see robust economic expansion in the coming years, reducing poverty and improving access to healthcare. This bodes well for the adoption of high-performance blood gas analyzers.
  • Integration of telemetry systems with blood gas analyzers: Integration of telemetry systems with blood gas analyzers has the potential to unlock significant opportunities in the global blood gas analyzers market. With remote patient monitoring gaining increased importance in healthcare, combining blood gas analyzers with telemetry allows continuous monitoring of patients from afar. This can help address several long-standing challenges. The ability to integrate with telemetry vastly improves the utility of blood gas analyzers, opening up newer clinical applications and setting the stage for higher adoption across care settings over the coming years. This presents lucrative growth opportunities for players in the blood gas analyzers market if they adapt to incorporate these fast-emerging connectivity capabilities.
  • Developing customized solutions for new applications: Developing customized solutions for new applications in the blood gas analyzers market presents a significant opportunity for growth. As medicine advances, the need for precise, timely blood gas analysis in new areas is expanding. Customizing existing blood gas analyzer technologies with additional biomarkers or parameters can help meet emerging diagnostic and monitoring requirements. For example, the ability to analyze multiple blood parameters from a single small sample is crucial in pediatrics. Customized analyzers that can provide accurate assessments of blood gases, electrolytes, and other critical biomarkers from smaller blood volumes would help facilitate improved care for neonates and infants. Similar customized solutions tuned for the analysis of alternative sample types like tears or interstitial fluid may also benefit certain patient groups or applications. The assessment of blood gas status is also increasingly important in fast-paced environments like emergency response and transport medicine. Portable analyzers incorporating customized sensors and calibration techniques designed for intermittent use and rough handling could aid treatment in the field.

Blood Gas Analyzers Market Report Coverage

Report Coverage Details
Base Year: 2022 Market Size in 2023: US$ 2.36 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 5.6% 2030 Value Projection: US$ 3.46 Bn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East & Africa: GCC Countries, Israel, South Africa, North Africa, and Central Africa and Rest of Middle East
Segments covered:
  • By Product Type: Instruments and Consumables
  • By Modality: Benchtop and Portable
  • By Application: Anesthesia Management, Critical Care, Cardiovascular Procedures, and Others
  • By End User: Hospitals and Clinics, Diagnostic Laboratories, Homecare Settings, and Others
Companies covered:

Radiometer Medical ApS, Werfen, Nova Biomedical, OPTI Medical Systems, Inc., Accurex Biomedical Pvt. Ltd., Siemens Healthcare GmbH, Medica Corporation, ERBA Diagnostics Inc., F. Hoffmann-La Roche Ltd., Convergent Technologies, Bio-Rad Laboratories, and EKF Diagnostics

Growth Drivers:
  • Increasing prevalence of chronic diseases
  • Advancements in blood gas analyzer technology 
  • Adoption for point-of-care testing
Restraints & Challenges:
  • High cost of blood gas analyzers 
  • Lack of awareness about blood gas tests 
  • Lack  of skilled professionals

Blood Gas Analyzers Market Trends:

  • Shift towards portable and handheld devices: The shift towards portable and handheld devices is having a significant impact on the global blood gas analyzers market. With the medical industry moving towards more point-of-care testing and smaller, easily transportable devices, the demand for portable blood gas analyzers is rising steadily. These compact analyzers allow for blood gas testing to be done near the patient or in the field rather than traditional desktop analyzers that require samples to be sent to centralized laboratories. This has many advantages for patients and healthcare systems. Portable devices can enable testing in remote or rural areas that may not have ready access to full medical facilities. This ensures patients receive faster treatment decisions based on blood gas results without the turnaround time from long-distance sample transport.
  • Growing demand for online connectivity and data management: The growing demand for online connectivity and data management has significantly influenced the global blood gas analyzers market in recent years. With more medical tests and patient monitoring being done remotely due to the COVID-19 pandemic, the ability to remotely collect, share, and interpret blood gas analysis results has become increasingly important. This has driven more healthcare organizations to invest in blood gas analyzers that come with cloud-based data management software and mobile apps. Devices that can transmit patient data like blood gas, electrolyte, and metabolite levels online in real-time allow doctors to monitor high-risk cases remotely and make timely medical decisions.
  • Miniaturization of medical devices: The global transition towards miniaturization of medical devices is having a significant impact on the blood gas analyzers market. As devices get smaller and more portable, there is a growing demand for point-of-care testing equipment like miniaturized blood gas analyzers. These compact analyzers allow for blood gas analysis to be conducted near the patient's bedside or in other decentralized locations like intensive care units, emergency rooms, ambulances, and physician offices.

Blood Gas Analyzers Market Restraints:

  • High cost of blood gas analyzers: The high cost of blood gas analyzers is one of the major factors limiting the widespread adoption of these devices, especially in developing regions and resource-constrained settings. Blood gas analyzers are generally more expensive than routine clinical chemistry analyzers due to the advanced technologies and sensors used for rapid analysis of blood gas parameters. The instruments themselves have significant price tags, ranging from approximately US$ 25,000 to US$ 200,000 or more depending on the model and features. Additionally, facilities must invest in regular maintenance, calibration services, consumables like electrodes and cartridges, and technique validator kits that are required for quality assurance. These additional expenditures contribute to the overall cost of ownership and long-term operational expenses.
  • Lack of awareness about blood gas testing: The lack of awareness about blood gas testing among common people and physicians is significantly hampering the growth of the global blood gas analyzers market. Blood gas analysis provides crucial insights about the acid-base and electrolyte balance in human body by measuring levels of gases like oxygen, carbon dioxide, and bicarbonate along with other critical electrolytes. However, many people are still not familiar with the clinical importance and advantages of blood gas testing. They remain unsure about the types of medical conditions where such tests are necessary and the kind of timely interventions or treatments that depend on blood gas results. Even among medical practitioners, the understanding about clinical utility and appropriate usage of blood gas analyzers is limited in some regions and patient populations. This is more prevalent in primary care settings and developing countries where access to diagnostic resources and continuing medical education are still evolving. As a result, blood gas tests are often underutilized even in situations where they could hasten decision making, expedite life-saving interventions and improve healthcare outcomes.
  • Lack of skilled professionals: The shortage of skilled professionals is posing a major challenge for the growth of the global blood gas analyzers market. Blood gas analyzers require highly trained medical technicians and nurses to operate them and interpret the results. However, there is a rising deficit of such trained medical personnel worldwide. Both developing and developed countries are facing an acute shortage of skilled healthcare workers. For example, according to the World Health Organization (WHO), there is a global shortfall of over 18 million healthcare professionals. The situation is more severe in developing nations where the patient to healthcare worker ratio is extremely high. Countries like India, Brazil, South Africa, and Indonesia are struggling with severe shortages. This lack of skilled medical staff negatively impacts the effective use of advanced medical technologies like blood gas analyzers.

Recent Developments

New product launches/approvals

  • In July 2022, EDAN Instruments, Inc., a healthcare company, announced the launch of the first-of-its-kind POC (Point-of-Care) fluorescence-based CO-OX blood gas and chemistry analysis system, i20, equipped with over 45 parameters ranging from blood gases to electrolytes to CO-oximetry, at the 74th American Association for Clinical Chemistry Annual Scientific Meeting and Clinical Laboratory Exposition (2022 AACC)
  • In September 2021, Sensa Core Medical Instrumentation, a research & development-focused firm, announced the introduction of its flagship Blood Gas Analyzer ST-200CC Blood Gas Analyzers - Ultra Smart for hospitals, clinics, and diagnostics centers in India via its network
  • In April 2020, Siemens Healthineers, a Germany-based healthcare solutions and services provider, announced that its latest critical care testing solution, the RAPIDPoint 500e Blood Gas Analyzer, has received the U.S. Food and Drug Administration clearance and is now available in the U.S., Europe, and countries requiring the CE mark

Partnership and Acquisition

  • In July 2022, Radiometer Medical ApS, a multinational corporation that develops blood gas analyzers, partnered with Technicon A/S, a robot technology company, on a robotic solution — a cobot— to minimize manual effort in the blood collection process for users of Radiometer ABL800 FLEX blood gas analyzers in the Nordics. A collaborative robot designed for human-robot interaction is called a cobot.
  • In April 2023, Quest Diagnostics, a provider of diagnostic information services, and Haystack Oncology, an early-stage oncology company, announced a definitive agreement for Quest to acquire Haystack Oncology  in an all-cash equity transaction

Figure 2. Global Blood Gas Analyzers Market Share (%), By Product Type, 2023


To learn more about this report, request a free sample copy

Top Companies in the Blood Gas Analyzers Market

  • Radiometer Medical ApS
  • Werfen
  • Nova Biomedical
  • OPTI Medical Systems, Inc.
  • Accurex Biomedical Pvt. Ltd.
  • Siemens Healthcare GmbH
  • Medica Corporation
  • ERBA Diagnostics Inc.
  • F. Hoffmann-La Roche Ltd.
  • Convergent Technologies
  • Bio-Rad Laboratories
  • EKF Diagnostics

Definition: Blood gas analyzers are medical devices used to measure acidity (pH), oxygen (pO2), carbon dioxide (pCO2), and electrolyte levels in the blood. There are two main types of these analyzers - point-of-care testing devices and central laboratory devices. Point-of-care devices are portable instruments that can be used at the patient's bedside to provide rapid results within 5-15 minutes. This allows for quick clinical decision making during emergencies and procedures. Central laboratory devices are larger benchtop models located inside hospital laboratories. They have higher throughput and can run more samples simultaneously but results may take 30-45 minutes.

Frequently Asked Questions

The global blood gas analyzers market is estimated to be valued at US$ 2.36 Bn in 2023 and is expected to exhibit a CAGR of 5.6%  between 2023 and 2030.

Increasing prevalence of chronic diseases, advancements in blood gas analyzer technology, and adoption of point-of-care testing are expected to drive the market growth.

Instruments is the leading product type segment in the market.

The high cost of blood gas analyzers, lack of awareness about blood gas testing and lack of skilled professionals is expected to hinder the market growth over the forecast period.

The major players operating in the market are Radiometer Medical ApS, Werfen, Nova Biomedical, OPTI Medical Systems, Inc., Accurex Biomedical Pvt. Ltd., Siemens Healthcare GmbH, Medica Corporation, ERBA Diagnostics Inc., F. Hoffmann-La Roche Ltd., Convergent Technologies, Bio-Rad Laboratories, and EKF Diagnostics.

View Our Licence Options

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now

Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

Request Discount

Reliability and Reputation

DUNS Registered
DMCA Protected


Reliability and Reputation


Reliability and Reputation


Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo